2025 Genetic Toxicology Association Annual Meeting

HESI is pleased to announce that several of its scientific programs will be featured at the 2025 Annual Meeting of the Genetic Toxicology Association (GTA). This year’s meeting will spotlight innovative approaches to genotoxicity and carcinogenicity testing, and HESI is proud to contribute through multiple committee-led presentations that reflect our mission to collaboratively advance science for a safer, more sustainable world.

HESI-Led Workshop, Wednesday May 7th, 4:00-6:00PM ET
The Last Mile: Opportunities to Bridge Research and Increase Impact in Human and Environmental Health Sciences
Session Chairs: Raechel Puglisi (HESI) & Connie Chen (HESI)

• Raechel Puglisi (HESI): Defining the Last Mile: The Bridge Between Research and Impact (GTTC)
• Srijit Seal (Merck): HESI eSTAR OASIS: Leveraging ‘Omics Data for Next Gen Safety Assessment (eSTAR)
• Stefan Pfuhler (Procter & Gamble): HESI Botanical Safety Consortium: Towards a Global Genotoxicity Testing Strategy for Botanicals (BSC)
• Carole Yauk (University of Ottawa): From Discovery to Validation and Implementation: The Journey of the TGx-DDI Biomarker (eSTAR)

Additional HESI Presentation:
Toward More Predictive and Human-Relevant Carcinogenicity Testing: Establishing Study Design and Approach for Detecting Cancer Driver Gene Mutations Using Duplex Sequencing (eSTAR)
James Alper Alcaraz (University of Ottawa)

This dynamic presence at GTA 2025 highlights HESI’s multi-sector commitment to translating cutting-edge science into practical tools that inform decision-making and regulatory guidance. We invite all attendees to join these sessions and engage with HESI staff and collaborators on the latest in genetic toxicology innovation.